Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: Experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee

Journal of Clinical Oncology

Volumn 23, Issue 19, 2005, Pages 4363-4371

  Orbach, Daniel ^a   Rey, A ^a   Oberlin, O ^a   Sanchez De Toledo, J ^a   Terrier Lacombe, M J ^a   Van Unnik, A ^a   Quintana, E ^a   Stevens, M C G ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; TENIPOSIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; CEV PROTOCOL; CYCLOPHOSPHAMIDE; EPIRUBICIN; IVA PROTOCOL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; ENTEROPATHY; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; INFANT; INFECTION; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MESENCHYMOMA; NEUROLOGIC DISEASE; ONCOLOGY; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; AGE; CLINICAL TRIAL; COMPARATIVE STUDY; METASTASIS; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; SARCOMA; SURVIVAL; TUMOR RECURRENCE;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; HUMANS; IFOSFAMIDE; INFANT; INFANT, NEWBORN; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RHABDOMYOSARCOMA; SARCOMA; SURVIVAL ANALYSIS; TENIPOSIDE; VINCRISTINE;

EID: 22344435175     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.12.009     Document Type: Article

References (24)

1. Coffin CM, Dehner LP: Soft tissue tumors in first year of life: A report of 190 cases. Pediatr Pathol 10:509-526, 1990
2. Campbell AN, Chan HS, O'Brien A, et al: Malignant tumours in the neonate. Arch Dis Child 62:19-23, 1987
3. Ragab AH, Heyn R, Tefft M, et al: Infants younger than 1 year of age with rhabdomyosarcoma. Cancer 58:2606-2610, 1986
4. Isaacs H Jr: Perinatal (congenital and neonatal) neoplasms: A report of 110 cases. Pediatr Pathol 3:165-216, 1985
5. Isaacs H Jr: Congenital and neonatal malignant tumors: A 28-year experience at Children's Hospital of Los Angeles. Am J Pediatr Hematol Oncol 9:121-129, 1987
6. Hayes-Jordan AA, Spunt SL, Poquette CA, et al: Nonrhabdomyosarcoma soft tissue sarcomas in children: Is age at diagnosis an important variable? J Pediatr Surg 35:948-953, 2000
7. Crist WM, Anderson JR, Meza JL, et al: Intergroup rhabdomyosarcoma study: IV. Results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102, 2001
8. Ferrari A, Casanova M, Bisogno G, et al: Rhabdomyosarcoma in infants younger than one year old: A report from the Italian Cooperative Group. Cancer 97:2597-2604, 2003
9. Joshi D, Anderson JR, Paidas C, et al: Age is an independent prognostic factor in rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 42:64-73, 2004
10. Koscielniak E, Harms D, Schmidt D, et al: Soft tissue sarcomas in infants younger than 1 year of age: A report of the German Soft Tissue Sarcoma Study Group (CWS-81). Med Pediatr Oncol 17:105-110, 1989
11. Dillon PW, Whalen TV, Azizkhan RG, et al: Neonatal soft tissue sarcomas: The influence of pathology on treatment and survival-Children's Cancer Group Surgical Committee. J Pediatr Surg 30:1038-1041, 1995
12. Lobe TE, Wiener ES, Hays DM, et al: Neonatal rhabdomyosarcoma: The IRS experience. J Pediatr Surg 29:1167-1170, 1994
13. Stiller CA, Stevens MC, Magnani C, et al: Survival of children with soft-tissue sarcoma in Europe since 1978: Results from the EUROCARE study. Eur J Cancer 37:767-774, 2001
14. Morgan E, Baum E, Breslow N, et al: Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study. J Clin Oncol 6:51-55, 1988
15. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: Results of the second study of the International Society of Paediatric Oncology-MMT 84. Eur J Cancer 34:1050-1062, 1998
16. Sanchez de Toledo JOO, Bouvet-Forteau N, Praquin M-T, et al: Treatment of non metastatic rhabdomyosarcoma (RMS): Final report from the SIOP MMT 89 study. Med Pediatr Oncol 37:193, 2001 (abstr)
17. Carli M, Colombatti R, Oberlin O, et al: High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol 17:2796-2803, 1999
18. Donaldson SS, Draper GJ, Flamant F, et al: Topography of childhood tumors: Pediatric coding system. Pediatr Hematol Oncol 3:249-258, 1986
19. Rodary C, Flamant F, Donaldson SS: An attempt to use a common staging system in rhabdomyosarcoma: A report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 17:210-215, 1989
20. Newton WA Jr, Gehan EA, Webber BL, et al: Classification of rhabdomyosarcomas and related sarcomas: Pathologic aspects and proposal for a new classification-An Intergroup Rhabdomyosarcoma Study. Cancer 76:1073-1085, 1995
21. Skinner R, Sharkey IM, Pearson AD, et al: Ifosfamide, mesna, and nephrotoxicity in children. J Clin Oncol 11:173-190, 1993
22. Grundy R, Anderson J, Gaze M, et al: Congenital alveolar rhabdomyosarcoma: Clinical and molecular distinction from alveolar rhabdomyosarcoma in older children. Cancer 91:606-612, 2001
23. Kynaston JA, Malcolm AJ, Craft AW, et al: Chemotherapy in the management of infantile fibrosarcoma. Med Pediatr Oncol 21:488-493, 1993
24. Parkes SE, Muir KR, Southern L, et al: Neonatal tumours: A thirty-year population-based study. Med Pediatr Oncol 22:309-317, 1994